Fruquintinib as new treatment option in metastatic colorectal cancer patients: is there an optimal sequence?
Erika StucchiMichela BartoliniMarco AiroldiRoberta FazioValentina DapràGiuseppe MondelloMaria Giuseppina PreteAlberto PucciniArmando SantoroPublished in: Expert opinion on pharmacotherapy (2024)
or HER2 amplification) and in non-oncogenic driven patients.